Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate

Nicotine and Tobacco Research

Volumn 13, Issue 10, 2011, Pages 1003-1008

  Covey, Lirio S ^a   Hu, Mei Chen ^b   Weissman, Judith ^c   Croghan, Ivana ^d   Adler, Lenard ^e   Winhusen, Theresa ^f  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Department of Medicine   (United States)

^c WEILL CORNELL MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; METHYLPHENIDATE; NICOTINE PATCH; PLACEBO;

ADULT; AGED; ALCOHOL ABUSE; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; CIGARETTE SMOKING; COMORBIDITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG DELIVERY SYSTEM; DRUG DOSE INCREASE; DRUG TOLERABILITY; EDUCATIONAL STATUS; EMPLOYMENT STATUS; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARRIAGE; NICOTINE REPLACEMENT THERAPY; OSMOTIC RELEASE ORAL SYSTEM; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGE FACTORS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIRECTIVE COUNSELING; DOUBLE-BLIND METHOD; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METHYLPHENIDATE; MIDDLE AGED; ODDS RATIO; SMOKING; TOBACCO USE CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 80053496357     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr087     Document Type: Article

References (31)

1. Adler, L. A., & Cohen, J. (2004). Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder. Psychiatric Clinic North America, 7, 187-201. doi:10.1016/j.psc.2003.12.003.
2. Adler, L. A., Spencer, T., Faraone, S. V., Reimherr, F. W., Kelsey, D., Michelson, D., et al. (2005). Training raters to assess adult ADHD: Reliability of ratings. Journal of Attention Disorders, 8, 121-126. doi:10.1177/1087054705277168.
3. Andrews, G., & Peters, L. (1998). The psychometric properties of the Composite International Diagnostic Interview. Social Psychiatry and Psychiatric Epidemiology, 33, 80-88. doi:10.1007/s001270050026.
4. Barbaresi, W. J., Katusic, S. K., Colligan, R. C, Weaver, A. L. Leibson C. L., & Jacobsen, S. J. (2006). Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. Journal of Developmental and Behavioral Pediatrics, 27, 1-10.
5. Biederman, J., & Pliszka, S. R. (2008). Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents. Journal of Pediatrics, 152, 394-10.
6. Chou, W.J., Chou, M.C., Tzang, R.F., Hsu, Y.C., Gau, S.S., Chen, S. J., et al. (2009). Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes. Psychiatry and Clinical Neurosciences, 63, 167-75. doi: 10.1111/j.1440-1819.2009.01937.x.
7. Coghill, D., & Seth, S. (2011). Do the diagnostic criteria for ADHD need to change? Comments on the preliminary proposals of the DSM-5 ADHD and Disruptive Behavior Disorders Committee. European Child & Adolescent Psychiatry, 20, 75-81. doi:10.1007/s00787-010-0142-4.
8. Covey, L. S., Hu, M. C., Winhusen, T., Weissman, J., Berlin, I., & Nunes, E. V. (2010). OROS-methylphenidate or placebo for adult smokers with attention deficit hyperactivity disorder: Racial/ethnic differences. Drug and Alcohol Dependence, 110, 156-159. doi:10.1016/j.drugalcdep.2010.02.002.
9. Covey, L. S., Manubay, J., Jiang, H., Nortick, M., & Palumbo, D. (2008). Smoking cessation and inattention or hyperactivity/impulsivity: A post hoc analysis. Nicotine & Tobacco Research, 10, 1717-1725. doi:10.1080/14622200802443536.
10. de Meneses-Gaya, I. C., Zuardi, A. W., Loureiro, S., & de Souza Crippa, J. A. (2009). Psychometric properties of the Fagerstrom Test for Nicotine Dependence. Jornal Brasileiro de Pneumologia, 35, 73-82. doi:10.1590/S1806-37132009000100011.
11. Döpfner, M., Steinhausen, H. C., Coghill, D., Dalsgaard, S., Poole, L., Ralston, S. J., et al. (2006). Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study. European Child and Adolescent Psychiatry, 15(Suppl. 1), 146-155. doi:10.1007/s00787-006-1007-8.
12. DuPaul, G. J., Power, T. J., Anastopoulos, A. D., & Reid, R. (1998). Adhd rating scale-iv: checklists, norms, and clinical interpretation. New York, NY: The Guilford Press.
13. Elkins, I. J., McGue, M., & Iacono, W. H. (2007). Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Archives of General Psychiatry, 64, 1145-1152.
14. Fuemmeler, B. F., Kollins, S. H., & McClernon, F. J. (2007). Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. Journal of Pediatric Psychology, 32, 1203-1213. doi:10.1093/jpepsy/jsm051.
15. Gorman, E. B., Klorman, R., Thatcher, J. E., & Borgstedt, A. D. (2006). Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. Journal of the American Academy for Child and Adolescent Psychiatry, 45, 808-816. doi:10.1097/01.chi.0000214191.57993.dd.
16. Gray, K. M., & Upadhyaya, H. P. (2009). Tobacco smoking in individuals with attention-deficit hyperactivity disorder: Epidemiology and pharmacological approaches to cessation. CNS Drugs, 23, 661-668. doi:10.2165/00023210-200923080-00003.
17. Grizenko, N., Paci, M., & Joober, R. (2010). Is the inattentive subtype of ADHD different from the combined/hyperactive subtype? Journal of Attention Disorders, 13, 649-657. doi:10.1177/1087054709347200.
18. Hughes, J. R., Keely, J. P., Niaura, R. S., Ossip-Klein, D. J., Richmond, R. L., & Swan, G. E. (2003). Measures of abstinence in clinical trials: Issues and recommendations. Nicotine & Tobacco Research, 5, 13-25. doi:10.1093/ntr/5.1.13.
19. Jarvis, M. J., Tunstall-Pedoe, H., Feyerabend, C., Vesey, C., & Saloojee, Y. (1987). Comparison of tests to distinguish smokers from nonsmokers. American Journal of Public Health, 77, 1435-1438. doi:10.2105/AJPH.77.11.1435.
20. Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., et al. (2006). The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. American Journal of Psychiatry, 163, 716-723. doi:10.1176/appi.ajp.163.4.716.
21. Kessler, R. C., Green, J. G., Adler, L. A., Barkley, R. A., Chatterji, S., Faraone, S. V., et al. (2010). Structure and diagnosis of adult attention-deficit/hyperactivity disorder: Analysis of expanded symptom criteria from the Adult ADHD Clinical Diagnostic Scale. Archives of General Psychiatry, 67, 1168-1178. doi:10.1001/archgenpsychiatry.2010.146.
22. Kollins, S. H., McClernon, F. J., & Fuemmeler, B. F. (2005). Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Archives of General Psychiatry, 62, 1142-1147. doi:10.1001/archpsyc.62.10.1142.
23. Moolchan, E. T., Radzius, A., Epstein, D. H., Uhl, G., Gorelick, D. A., Cadet, J. L., et al. (2002). The Fagerstrom Test for Nicotine Dependence and the Diagnostic Interview Schedule: Do they diagnose the same smokers? Addictive Behavior, 27, 101-113. doi:10.1016/S0306-4603(00)00171-4.
24. Polanczyk, G., de Lima, M. S., Horta, B. L., Biederman, J., & Rohde, L. A. (2007). The worldwide prevalence of ADHD: A systematic review and metaregression analysis. American Journal of Psychiatry, 164, 942-948. doi:10.1176/appi.ajp.164.6.942.
25. Riley, C., DuPaul, C. J., Pipan, M., Kern, L., Van Brakle, J., & Blum, M. J. (2008). Combined type versus ADHD predominantly hyperactive-impulsive type: Is there a difference in functional impairment? Journal of Developmental and Behavioral Pediatrics, 29, 270-275. doi:10.1097/DBP.0b013e31816b6afe.
26. Rösler, M., Retz, W., & Stieglitz, R. D. (2010). Psychopathological rating scales as efficacy parameters in adult ADHD treatment investigations-Benchmarking instruments for international multicentre trials. Pharmacopsychiatry, 43, 92-98. doi:10.1055/s-0029-1242819.
27. Rukstalis, M., Jepson, C., Patterson, F., & Lerman, C. (2005). Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. Journal of Substance Abuse Treatment, 28, 297-304. doi:10.1016/j.jsat.2005.02.002.
28. Sobell, L. C., & Sobell, M. B. (1992). Timeline follow back: A technique for assessing self-reported ethanol consumption. In J. Allen & R. Litten (Eds.), Measuring alcohol consumption. Psychosocial & behavioral methods (pp 41-72). Totowa, NJ: Humana Press.
29. Volk, H. E., Henderson, C., Neuman, R. J., & Todd, R. D. (2006). Validation of population-based ADHD subtypes and identification of three clinically impaired subtypes. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141B, 312-318. doi:10.1002/ajmg.b.30299.
30. Wilens, T. E., Biederman, J., Faraone, S. V., Martelon, M., Westerberg, D., & Spencer, T. J. (2009). Presenting ADHD symptoms, subtypes, and comorbid disorders in clinically referred adults with ADHD. Journal of Clinical Psychiatry, 70, 1557-1562. doi:10.4088/JCP.08m04785pu.
31. Winhusen, T., Somoza, E., Brigham, G. S., Liu, D., Green, C. A., Covey, L., et al. (2010). A double-blind placebo-controlled trial in smokers with attention deficit hyperactivity disorder (ADHD). Journal of Clinical Psychiatry, 71, 1680-1688. doi:10.4088/JCP.09m05089gry.